BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 955266)

  • 1. Pathogenicity, immunogenicity and genetic stability in mice and ferrets of a cold inhibitor-resistant mutant of influenza H3N2 virus.
    Závadová H; Stárek M; Dolezalová B; Vonka V
    Dev Biol Stand; 1976; 33():151-4. PubMed ID: 955266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on pathogenicity and immunogenicity of cold adapted variants of influenza virus.
    Brydak L
    Acta Microbiol Pol; 1982; 31(3-4):287-92. PubMed ID: 6189378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passive serum antibody causes temporary recovery from influenza virus infection of the nose, trachea and lung of nude mice.
    Kris RM; Yetter RA; Cogliano R; Ramphal R; Small PA
    Immunology; 1988 Mar; 63(3):349-53. PubMed ID: 2832312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protection of ferrets against influenza by immunization with a split influenza vaccine.
    Brady MI; Furminger IG
    Dev Biol Stand; 1975; 28():167-72. PubMed ID: 1126566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies of the adaptation of influenza viruses to lowered temperatures of replication. II. Studies in vivo].
    Brydak L; Sadowski W
    Med Dosw Mikrobiol; 1990; 42(1-2):50-3. PubMed ID: 1964991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
    Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL
    Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro markers for measuring residual virulence for men of live attenuated influenza viruses.
    Boudreault A; Diaz-Rodriguez P; Lecomte J
    Dev Biol Stand; 1977 Jun 1-3; 39():33-40. PubMed ID: 604117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets.
    Herlocher ML; Truscon R; Elias S; Yen HL; Roberts NA; Ohmit SE; Monto AS
    J Infect Dis; 2004 Nov; 190(9):1627-30. PubMed ID: 15478068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of resistance to influenza virus infection in animal models.
    Potter CW; McLaren C; Jennings R
    Dev Biol Stand; 1975; 28():307-18. PubMed ID: 1126574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ts mutant of NWS influenza virus: behaviour in vitro and in vivo.
    Tucková E; Svobodová J; Anisimová E; Doleźalová B; Vonka V; Stárek M
    Acta Virol; 1976 Aug; 20(4):305-12. PubMed ID: 9820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of ferrets to infection with a live attenuated influenza virus and to subsequent heterologous challenge.
    Delem A
    Dev Biol Stand; 1976; 33():226-33. PubMed ID: 955269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory and clinical characteristics of attenuated strains of influenza virus.
    Maassab HF; Francis T; Davenport FM; Hennessy AV; Minuse E; Anderson G
    Bull World Health Organ; 1969; 41(3):589-94. PubMed ID: 5309481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombination of influenza A virus strains: effect on pathogenicity.
    Ennis FA; Verbonitz M; Reichelderfer P; Daniel S
    Dev Biol Stand; 1976; 33():220-5. PubMed ID: 955268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenicity and antigenicity of a new influenza A (H5N1) virus isolated from duck meat.
    Lu X; Cho D; Hall H; Rowe T; Sung H; Kim W; Kang C; Mo I; Cox N; Klimov A; Katz J
    J Med Virol; 2003 Apr; 69(4):553-9. PubMed ID: 12601764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
    Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of genetic properties of influenza viruses before and after repeated passages in monkey kidney cell culture.
    Tucková E; Vonka V; Stárek M
    Acta Virol; 1968 Jul; 12(4):316-23. PubMed ID: 4386016
    [No Abstract]   [Full Text] [Related]  

  • 17. Purification and properties of an influenza virus inhibitor isolated from mouse lungs.
    Lobodzińska M; Krizanová O
    Acta Virol; 1966 Jan; 10(1):28-34. PubMed ID: 4380768
    [No Abstract]   [Full Text] [Related]  

  • 18. Maternal-infant transfer of influenza-specific immunity in the mouse.
    Reuman PD; Paganini CM; Ayoub EM; Small PA
    J Immunol; 1983 Feb; 130(2):932-6. PubMed ID: 6848601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance of mice immunized per os with A2 influenza virus to intranasal challenge with a pathogenic strain.
    Sidorova LA; Alekseyeva AK
    Acta Virol; 1973 Jul; 17(4):298-304. PubMed ID: 4148209
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of development of resistance to antivirals in the ferret model of influenza virus infection.
    Herlocher ML; Truscon R; Fenton R; Klimov A; Elias S; Ohmit SE; Monto AS
    J Infect Dis; 2003 Nov; 188(9):1355-61. PubMed ID: 14593594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.